Dianthus Therapeutics (DNTH) Short Interest
Nasdaq • DNTH • US2528281080
As of Oct 22, 2026, ORTEX estimated 16% of free float sold short, 9.1 days to cover, cost to borrow 0.52%. Sign up for live short interest data.
Nasdaq • DNTH • US2528281080
As of Oct 22, 2026, ORTEX estimated 16% of free float sold short, 9.1 days to cover, cost to borrow 0.52%. Sign up for live short interest data.
This page tracks how heavily Dianthus Therapeutics (Nasdaq:DNTH) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Dianthus Therapeutics (Nasdaq: DNTH) has a market capitalization of $4.84B. Last close $86.03 (as of 2026-11-09); 52-week range $34.29 to $117.88. ORTEX data as of 2026-10-22: short interest was 16% of free float, 9.1 days to cover and the average cost to borrow was 0.52%. Sign up for live short interest data.